CORE-ABR
Sales sheet Request a demo

Pathogen

Chlamydia trachomatis

An obligate intracellular bacterium and the most commonly reported bacterial STI in the United States.

Also: chlamydia

Atypical and cell-wall-deficient bacteriaSTI panelIdentified · not antibiotic-graded

On the report

Therapy follows current CDC STI treatment guidelines. Beta-lactams are not relied on for chlamydial infection.

Reportable in all U.S. states.

What the report shows for Chlamydia trachomatis

  • Detected or not detected, with Ct, limit of detection and cycles above LOD — see PCR reporting.
  • A short pathogen summary, including colonizer likelihood where it applies.
  • No antibacterial grades — the report identifies the organism and points to guideline management instead.
  • When not detected, it is still listed among targets tested.

Tagged

Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.